Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) rose 16.4% on Wednesday . The company traded as high as GBX 1.63 and last traded at GBX 1.63. Approximately 485,718 shares were traded during mid-day trading, a decline of 29% from the average daily volume of 687,415 shares. The stock had previously closed at GBX 1.40.
Cizzle Biotechnology Trading Up 4.8%
The stock has a market cap of £6.44 million, a price-to-earnings ratio of -5.08 and a beta of 0.38. The company has a 50 day simple moving average of GBX 1.61 and a 200-day simple moving average of GBX 1.54.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
See Also
- Five stocks we like better than Cizzle Biotechnology
- Buy Alert: $8 AI Stock
- 53% Gains In 4 Years. Then 51% In Under 11 Months.
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
